Specific Amino Acids in HIV-1 VPR Are Significantly Associated With Differences in Patient Neurocognitive Status

Journal of NeuroVirology - United Kingdom
doi 10.1007/s13365-016-0462-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Controversies in HIV-associated Neurocognitive Disorders

The Lancet Neurology
Neurology
2014English

HIV-1 Accessory Proteins: VpR

Methods in Molecular Biology
GeneticsMolecular Biology
2014English

The Cross-Talk of HIV-1 Tat and Methamphetamine in HIV-associated Neurocognitive Disorders

Frontiers in Microbiology
Microbiology
2015English

Serum Branched Chain Amino Acids Are Associated With Type 2 Diabetes Mellitus in Jordan

Korean Journal of Family Medicine
Family Practice
2018English

Role of FOXO3 Activated by HIV-1 Tat in HIV-Associated Neurocognitive Disorder Neuronal Apoptosis

Frontiers in Neuroscience
Neuroscience
2019English

Yeast Perspectives on HIV-1 VPR

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2000English

P218 Determining the Neurocognitive Status and Functional Ability to Screen for HIV-associated Neurocognitive Disorder (HAND)

2019English

HIV-1 VPR Counteracts HLTF-mediated Restriction of HIV-1 Infection in T Cells

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2019English

Adiponectin and Interleukin-6, but Not Adipose Tissue, Are Associated With Worse Neurocognitive Function in HIV-infected Men

Antiviral Therapy
Infectious DiseasesPharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy